caffeine and haloperidol

caffeine has been researched along with haloperidol in 90 studies

Research

Studies (90)

TimeframeStudies, this research(%)All Research%
pre-199030 (33.33)18.7374
1990's13 (14.44)18.2507
2000's27 (30.00)29.6817
2010's19 (21.11)24.3611
2020's1 (1.11)2.80

Authors

AuthorsStudies
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET1
Blake, JF; Curatolo, WJ; Lombardo, F1
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B1
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY2
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Ahman, M; Holmén, AG; Wan, H1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Glen, RC; Lowe, R; Mitchell, JB1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F1
Sen, S; Sinha, N1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chłoń-Rzepa, G; Dąbrowska, M; Jankowska, A; Komsta, Ł; Pawłowski, M; Ślusarczyk, M; Starek, M; Zagórska, A1
Boissier, JR; Dumont, C; Oberlander, C; Peterfalvi, M1
Andén, NE; Jackson, DM1
Dreesen, R; Stüttgen, G1
Henry, G; King, DJ1
Calder, LD; Karler, R1
Hishinuma, S; Hongo, I; Kurokawa, M; Uchida, MK1
Rudas, N; Tondo, L1
Kuribara, H; Tadokoro, S1
Asami, T; Ida, I; Kuribara, H; Machiyama, Y; Tadokoro, S1
Caporali, MG; Popoli, P; Scotti de Carolis, A1
Fletcher, JE; Lizzo, FH; Rosenberg, H1
Hommer, DW; Skirboll, LR; Stoner, GR; Werkman, S1
Fujiwara, Y; Kazahaya, Y; Otsuki, S; Sandyk, R; Takeda, T1
La Cascia, C; Mascarella, A; Migneco, G; Navetta, A; Tripi, S1
Holloway, WR; Thor, DH1
Caporali, MG; de Carolis, AS; Popoli, P1
Matsubara, S; Omori, T1
Kalivas, PW1
Zetler, G1
Filippova, LM; Rapoport, IA; Zhurkov, VS1
Boissier, JR; Larousse, C; Simon, P; Villeneuve, A1
Atanassova-Shopova, S; Lazarova, MB; Roussinov, KS1
Bass, WC; Brown, H1
Ban, TA; Lehmann, HE1
Senault, B1
De Fina, V; Duzzi, L; Valsecchi, B1
Hance, AJ; Monti, JM1
Chandra, A; Lin, MT; Liu, GG1
Yonkov, DI1
Boadle-Biber, MC1
Schechter, MD1
Jones, RS; Olpe, HR; Steinmann, MW1
Ellison, G; Nelson, L; Potthoff, AD1
Mueller, K; Nyhan, WL; Palmour, R; Saboda, S1
Hirshkowitz, M; Karacan, I; Thornby, JI1
Castel, MN; Dagerlind, A; Hökfelt, T; Morino, P1
Collins, SP; Mendes, LS1
Dalia, A; Uretsky, NJ; Wallace, LJ1
Fredholm, BB; Nergårdh, R; Svenningsson, P1
Beuckmann, CT; Franke, H; Galla, HJ1
Dorsa, DM; Ward, RP1
Beilstein, MA; Chen, JF; Cuellar, B; Fink, JS; Grandy, DK; Hackett, E; Impagnatiello, F; Low, MJ; Moratalla, R; Ongini, E; Rubinstein, M; Schwarzschild, MA1
Ross, BM; Seeman, M; Turenne, SD1
Alvarez-Cervera, FJ; Arankowsky-Sandoval, G; Góngora-Alfaro, JL; Heredia-López, F; Moo-Puc, RE; Pineda, JC1
Costentin, J; El Yacoubi, M; Vaugeois, JM1
Bishnoi, M; Chopra, K; Kulkarni, SK1
Christopher, TA; Gao, F; Huang, Z; Liu, X; Lopez, B; Ma, X; Shi, G; Zhang, Y1
Grzelak, ME; Hodgson, RA; Hunter, JC; Parker, EM; Pond, AJ; Varty, GB1
Bateup, HS; Gong, S; Greengard, P; Heintz, N; Kuroiwa, M; Nishi, A; Svenningsson, P1
Barodia, SK; Luthra, PM; Raghubir, R1
Ballero, M; Barhate, S; Kasture, S; Maxia, A; Mohan, M; Sanna, C1
Collins, LE; Farrar, AM; Font, L; Nunes, EJ; Patel, V; Sager, TN; Salamone, JD; Schlar, DE1
Goode, T; Harris, A; Trevitt, J; Vallance, C1
Adams, C; Bilsky, EJ; Cormier, J; Dunbar, C; Mercer, H; Negus, SS; Stevenson, GW1
Alvarez-Cervera, FJ; Bata-García, JL; Góngora-Alfaro, JL; Heredia-López, FJ; Moo-Puc, RE; Pineda, JC; Villanueva-Toledo, JR1
Eyanagi, R; Imoto, M; Kuroki, H; Nishimura, S; Shimeno, H; Soeda, S; Toda, A; Uchiyama, H; Watanabe, S1
Cerimele, JM; Jutras-Aswad, D; Stern, AP1
Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC1
Acuña-Lizama, MM; Alvarez-Cervera, FJ; Bata-García, JL; Góngora-Alfaro, JL1
Acquas, E; Arote, S; Cotti, E; Gaikar, M; Kasture, SB; Kasture, V; Rosas, M; Salve, B1
Engmann, O; Giralt, A; Girault, JA1
Ain, R; Drumm, M; Joshi, RS; Panicker, MM; Quadros, R1
Avvisati, L; Buonaguro, EF; de Bartolomeis, A; Iasevoli, F; Latte, G; Marmo, F; Tomasetti, C1
Anoopkumar-Dukie, S; Arora, D; Grant, GD; Hall, S; Kinra, M; Mallik, SB; Mudgal, J; Nampoothiri, M; Rao, CM1

Reviews

1 review(s) available for caffeine and haloperidol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for caffeine and haloperidol

ArticleYear
The effect of neuroleptics on cognitive and psychomotor function. A preliminary study in healthy volunteers.
    The British journal of psychiatry : the journal of mental science, 1992, Volume: 160

    Topics: Adult; Antipsychotic Agents; Arousal; Attention; Caffeine; Diazepam; Female; Flicker Fusion; Haloperidol; Humans; Life Change Events; Male; Neuropsychological Tests; Personality Inventory; Problem Solving; Psychomotor Performance; Reaction Time; Sensory Thresholds; Trihexyphenidyl

1992
Effects of psychoactive drugs on conflict avoidance behavior in human subjects.
    Activitas nervosa superior, 1971, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Amobarbital; Avoidance Learning; Caffeine; Child; Chlordiazepoxide; Chlorpromazine; Conflict, Psychological; Electroshock; Female; Haloperidol; Humans; Male; Meprobamate; Methamphetamine; Neurotic Disorders; Pentylenetetrazole; Perphenazine; Placebos; Tranquilizing Agents

1971

Other Studies

87 other study(ies) available for caffeine and haloperidol

ArticleYear
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium

1985
Computation of brain-blood partitioning of organic solutes via free energy calculations.
    Journal of medicinal chemistry, 1996, Nov-22, Volume: 39, Issue:24

    Topics: Animals; Blood-Brain Barrier; Brain; Cattle; Cells, Cultured; Endothelium, Vascular; Membrane Lipids; Microcirculation; Molecular Conformation; Molecular Structure; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Software; Solubility; Thermodynamics

1996
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
    Journal of medicinal chemistry, 2000, Jun-01, Volume: 43, Issue:11

    Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
    Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15

    Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water

2001
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13

    Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding

2002
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
    Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6

    Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2

    Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution

2011
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship

2011
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Estimation of the lipophilicity of purine-2,6-dione-based TRPA1 antagonists and PDE4/7 inhibitors with analgesic activity.
    Bioorganic & medicinal chemistry letters, 2021, 10-01, Volume: 49

    Topics: Analgesics; Benzeneacetamides; Cyclic Nucleotide Phosphodiesterases, Type 7; Hydrophobic and Hydrophilic Interactions; Molecular Structure; Phenylbutyrates; Phosphodiesterase 4 Inhibitors; Principal Component Analysis; Quantitative Structure-Activity Relationship; TRPA1 Cation Channel; Xanthines

2021
Pharmacological interactions with circling behaviour induced by the piperidinyl indole derivative RU 23686.
    Psychopharmacology, 1977, Nov-24, Volume: 55, Issue:1

    Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Caffeine; Drug Interactions; Haloperidol; Humans; Indoles; Male; Methyltyrosines; Methysergide; Motor Activity; Neurotransmitter Agents; Nialamide; Phenoxybenzamine; Propranolol; Rats; Reserpine; Scopolamine; Stereotyped Behavior

1977
Locomotor activity stimulation in rats produced by dopamine in the nucleus accumbens: potentiation by caffeine.
    The Journal of pharmacy and pharmacology, 1975, Volume: 27, Issue:9

    Topics: Animals; Caffeine; Dextroamphetamine; Dopamine; Drug Synergism; Haloperidol; Male; Motor Activity; Nialamide; Olfactory Bulb; Rats; Reserpine; Stimulation, Chemical; Time Factors

1975
Dopamine effects on the microcirculation and veins of the skin after local application and their changes by antagonistic drugs.
    Archives of dermatological research, 1979, Volume: 266, Issue:1

    Topics: Adult; Anesthesia, General; Caffeine; Child; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Guanethidine; Haloperidol; Humans; Infant; Microcirculation; Phentolamine; Skin; Veins

1979
Excitatory amino acids and the actions of cocaine.
    Brain research, 1992, Jun-05, Volume: 582, Issue:1

    Topics: Animals; Caffeine; Cocaine; Dextromethorphan; Dizocilpine Maleate; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; N-Methylaspartate; Pipecolic Acids; Quinoxalines; Rats; Rats, Inbred Strains; Seizures; Stereoisomerism; Stereotyped Behavior

1992
Haloperidol differentiates smooth muscle contractions induced by release of intracellularly stored Ca and by influx of extracellular Ca.
    General pharmacology, 1992, Volume: 23, Issue:2

    Topics: Animals; Caffeine; Calcium; Carbachol; Female; Guinea Pigs; Haloperidol; Histamine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Potassium

1992
The course of a seasonal bipolar disorder influenced by caffeine.
    Journal of affective disorders, 1991, Volume: 22, Issue:4

    Topics: Bipolar Disorder; Caffeine; Chlorpromazine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Middle Aged; Recurrence; Seasons

1991
The ambulation-increasing effect of buprenorphine in mice: comparison with the effect of morphine.
    Arukoru kenkyu to yakubutsu izon = Japanese journal of alcohol studies & drug dependence, 1991, Volume: 26, Issue:1

    Topics: Animals; Buprenorphine; Caffeine; Cocaine; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Locomotion; Male; Methamphetamine; Mice; Morphine; Naloxone; Pilocarpine; Scopolamine

1991
[Characteristics of antagonism between ceruletide and various central-acting drugs: investigation by means of ambulatory activity in mice].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1990, Volume: 96, Issue:6

    Topics: Animals; Bromocriptine; Caffeine; Ceruletide; Cocaine; Dose-Response Relationship, Drug; Drug Tolerance; Ephedrine; Haloperidol; Male; Methamphetamine; Methylphenidate; Mice; Morphine; Motor Activity; Scopolamine

1990
The role of the purinergic system in the control of stereotypy: relationship to D-1/D-2 dopamine receptor activity.
    Pharmacology, biochemistry, and behavior, 1989, Volume: 32, Issue:1

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Benzazepines; Caffeine; Carbamazepine; Dopamine Antagonists; Drug Interactions; Electroencephalography; Haloperidol; Male; Rabbits; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Purinergic; Stereotyped Behavior

1989
Effects of droperidol, haloperidol and ketamine on halothane, succinylcholine and caffeine contractures: implications for malignant hyperthermia.
    Acta anaesthesiologica Scandinavica, 1989, Volume: 33, Issue:3

    Topics: Animals; Caffeine; Contracture; Droperidol; Haloperidol; Halothane; Humans; Ketamine; Male; Malignant Hyperthermia; Rats; Rats, Inbred Strains; Succinylcholine

1989
Preferential effects of caffeine on limbic and cortical dopamine systems.
    Biological psychiatry, 1988, Apr-15, Volume: 23, Issue:8

    Topics: Animals; Caffeine; Diazepam; Frontal Lobe; Haloperidol; Limbic System; Male; Mesencephalon; Neural Pathways; Neurons; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Synaptic Transmission

1988
Inhibitory effects of carbamazepine on clonidine-induced aggressive behavior in mice.
    The International journal of neuroscience, 1988, Volume: 42, Issue:1-2

    Topics: Adenosine; Aggression; Animals; Behavior, Animal; Caffeine; Carbamazepine; Clonidine; Haloperidol; Male; Mice; Prazosin; Receptors, Cell Surface; Yohimbine

1988
[Cytolytic episodes during cirrhosis].
    La Clinica terapeutica, 1986, Jul-31, Volume: 118, Issue:2

    Topics: Antipyrine; Anxiety Disorders; Barbiturates; Caffeine; Cholestasis; Drug Therapy, Combination; Female; Haloperidol; Humans; Liver Cirrhosis; Maprotiline; Middle Aged; Recurrence; Temazepam; Time Factors

1986
Interactive effects of caffeine, 2-chloroadenosine and haloperidol on activity, social investigation and play fighting of juvenile rats.
    Pharmacology, biochemistry, and behavior, 1985, Volume: 22, Issue:3

    Topics: 2-Chloroadenosine; Adenosine; Aggression; Animals; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Male; Motor Activity; Rats; Receptors, Cell Surface; Receptors, Purinergic; Social Behavior

1985
Is the purinergic system involved in the control of pathological movements?
    European journal of pharmacology, 1987, Jun-04, Volume: 137, Issue:2-3

    Topics: Animals; Caffeine; Carbamazepine; Electroencephalography; Haloperidol; Male; Purines; Rabbits; Stereotyped Behavior

1987
Rapid cooling contracture in frog striated muscles treated with chlorpromazine and haloperidol.
    The Japanese journal of physiology, 1985, Volume: 35, Issue:2

    Topics: Animals; Caffeine; Chlorpromazine; Cold Temperature; Dantrolene; Haloperidol; Muscle Contraction; Muscles; Procaine; Ranidae; Time Factors; Toes

1985
Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system.
    The Journal of pharmacology and experimental therapeutics, 1985, Volume: 235, Issue:2

    Topics: Amphetamine; Animals; Behavior, Animal; Caffeine; Corpus Striatum; Dopamine; Enkephalin, Methionine; Haloperidol; Injections, Intraventricular; Limbic System; Male; Motor Activity; Neurotensin; Nucleus Accumbens; Rats; Rats, Inbred Strains; Tegmentum Mesencephali

1985
Drug-induced catalepsy as influenced by convulsant and anticonvulsant drugs.
    Neuropharmacology, 1973, Volume: 12, Issue:8

    Topics: Animals; Anticonvulsants; Arecoline; Bemegride; Caffeine; Catalepsy; Central Nervous System Stimulants; Drug Synergism; Ethosuximide; Haloperidol; Humans; Lobeline; Male; Mice; Mice, Inbred Strains; Nicotine; Nikethamide; Paraoxon; Pentylenetetrazole; Pilocarpine; Tetrabenazine; Tremorine; Trifluoperazine

1973
Investigation of the mutagenic activity of phenothiazines and other drug preparations.
    Soviet genetics, 1973, Dec-01, Volume: 7, Issue:8

    Topics: Animals; Caffeine; Chromosome Aberrations; Drosophila melanogaster; Gene Frequency; Genes, Lethal; Haloperidol; Larva; Mutagens; Mutation; Phenothiazines; Promethazine; Sex Chromosomes; Structure-Activity Relationship

1973
Flurothyl in mice: seizure, post-convulsive behavior, and interactions with psychotropic drugs.
    Canadian journal of physiology and pharmacology, 1968, Volume: 46, Issue:1

    Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Biperiden; Caffeine; Catalepsy; Central Nervous System Stimulants; Chlordiazepoxide; Chlorpromazine; Diazepam; Electroshock; Haloperidol; Humans; Imipramine; Iproniazid; Meprobamate; Monoamine Oxidase Inhibitors; Motor Activity; Parasympatholytics; Pargyline; Prenylamine; Procyclidine; Rats; Reflex; Reserpine; Seizures; Tranylcypromine

1968
Experimental study of the effect of lithium, haloperidol, caffeine and theophylline on convulsive seizure reactions.
    Acta physiologica et pharmacologica Bulgarica, 1974, Volume: 2

    Topics: Animals; Caffeine; Drug Synergism; Haloperidol; Lithium; Male; Rats; Seizures; Theophylline

1974
Effect of drugs on visually controlled avoidance behavior in rhesus monkeys: a psychophysical analysis.
    Psychopharmacologia, 1967, Volume: 11, Issue:2

    Topics: Anesthetics; Animals; Avoidance Learning; Caffeine; Chlorpromazine; Dextroamphetamine; Escape Reaction; Hallucinogens; Haloperidol; Haplorhini; Lysergic Acid Diethylamide; Male; Morphine; Parasympatholytics; Pentobarbital; Phencyclidine; Piperidines; Psychopharmacology; Size Perception; Strychnine; Visual Perception

1967
[Intraspecific aggressive behavior induced by apomorphine in the rat].
    Psychopharmacologia, 1970, Volume: 18, Issue:3

    Topics: Acepromazine; Age Factors; Aggression; Amitriptyline; Animals; Apomorphine; Atropine; Behavior, Animal; Caffeine; Chlordiazepoxide; Chlorpromazine; Dextroamphetamine; Diazepam; Drug Antagonism; Electroshock; Environment; Haloperidol; Humans; Hydroxyzine; Imipramine; Male; Meprobamate; Morphine; Rats; Reserpine; Sex Factors; Sound; Species Specificity; Thiazines; Thioridazine

1970
[Variations in toxicologic responses of rats in relation to the type of enteric administration].
    Bollettino chimico farmaceutico, 1967, Volume: 106, Issue:12

    Topics: Animals; Caffeine; Diet; Haloperidol; Isoniazid; Male; Papaverine; Phenylbutazone; Phenylhydrazines; Phosphoric Acids; Rats; Thiazoles

1967
Effects of haloperidol and trifluperidol on operant behavior in the rat.
    Psychopharmacologia, 1967, Volume: 12, Issue:1

    Topics: Animals; Antidepressive Agents; Butyrophenones; Caffeine; Conditioning, Operant; Fluorine; Haloperidol; Male; Piperidines; Placebos; Rats; Transfer, Psychology; Trifluperidol

1967
The effects of theophylline and caffeine on thermoregulatory functions of rats at different ambient temperatures.
    The Journal of pharmacy and pharmacology, 1980, Volume: 32, Issue:3

    Topics: Animals; Body Temperature Regulation; Caffeine; Drug Interactions; Haloperidol; Hydroxydopamines; Male; Phentolamine; Propranolol; Rats; Temperature; Theophylline

1980
Possible role of brain dopaminergic systems in the memory effects of central stimulants.
    Methods and findings in experimental and clinical pharmacology, 1984, Volume: 6, Issue:5

    Topics: Amphetamine; Animals; Avoidance Learning; Brain; Caffeine; Central Nervous System Stimulants; Dopamine; Haloperidol; Male; Memory; Rats; Rats, Inbred Strains; Strychnine

1984
Blockade by haloperidol of the increase in tryptophan hydroxylase activity induced by incubation of slices of brain stem with dibutyryl cyclic AMP.
    Biochemical pharmacology, 1982, Jun-15, Volume: 31, Issue:12

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Brain Stem; Bucladesine; Caffeine; Calcium; Haloperidol; Male; Rats; Theophylline; Tryptophan Hydroxylase

1982
Caffeine potentiation of apomorphine discrimination.
    Pharmacology, biochemistry, and behavior, 1980, Volume: 13, Issue:2

    Topics: Animals; Apomorphine; Caffeine; Cyclic AMP; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Prejudice; Rats

1980
The locus coeruleus: actions of psychoactive drugs.
    Experientia, 1983, Mar-15, Volume: 39, Issue:3

    Topics: Action Potentials; Animals; Atropine; Caffeine; Chlorpromazine; Desipramine; Haloperidol; Locus Coeruleus; Male; Neurons; Nicotine; Norepinephrine; Physostigmine; Psychotropic Drugs; Rats; Scopolamine

1983
Ethanol intake increases during continuous administration of amphetamine and nicotine, but not several other drugs.
    Pharmacology, biochemistry, and behavior, 1983, Volume: 18, Issue:4

    Topics: Alcohol Drinking; Amphetamine; Animals; Caffeine; Drinking Behavior; Drug Implants; Female; Haloperidol; Lysergic Acid Diethylamide; Mescaline; Nicotine; Phencyclidine; Rats; Secobarbital

1983
Self-injurious behavior produced in rats by daily caffeine and continuous amphetamine.
    Pharmacology, biochemistry, and behavior, 1982, Volume: 17, Issue:4

    Topics: Amphetamine; Animals; Behavior, Animal; Caffeine; Drug Administration Schedule; Drug Implants; Haloperidol; Humans; Male; Motor Activity; Rats; Self Mutilation

1982
Sleep spindles: pharmacological effects in humans.
    Sleep, 1982, Volume: 5, Issue:1

    Topics: Atropine; Azepines; Caffeine; Cerebral Cortex; Computers; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Evoked Potentials; Flurazepam; Haloperidol; Humans; N-Methylscopolamine; Phenobarbital; Scopolamine; Scopolamine Derivatives; Sleep Stages; Thalidomide; Tryptophan

1982
Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment.
    The European journal of neuroscience, 1994, Apr-01, Volume: 6, Issue:4

    Topics: Animals; Autoradiography; Caffeine; Corpus Striatum; Gene Expression Regulation; Haloperidol; Male; Methamphetamine; Neurotensin; Olfactory Bulb; Oligonucleotide Probes; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Substance P; Sulfur Radioisotopes; Time Factors

1994
The effects of the atypical antipsychotics clozapine, remoxipride and risperidone on the contractile characteristics of rat skeletal muscle in vitro.
    Pharmacological research, 1997, Volume: 36, Issue:6

    Topics: Animals; Antipsychotic Agents; Caffeine; Clozapine; Dantrolene; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Halothane; In Vitro Techniques; Muscle Contraction; Muscle Relaxants, Central; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Remoxipride; Risperidone; Trifluoperazine

1997
Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity.
    Brain research, 1998, Mar-30, Volume: 788, Issue:1-2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Benzazepines; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Dopamine Antagonists; Glutamic Acid; Haloperidol; Male; Motor Activity; Nucleus Accumbens; Quinpirole; Rats; Rats, Sprague-Dawley; Salicylamides

1998
Regional differences in the ability of caffeine to affect haloperidol-induced striatal c-fos mRNA expression in the rat.
    Neuropharmacology, 1998, Volume: 37, Issue:3

    Topics: Animals; Caffeine; Genes, fos; Haloperidol; In Situ Hybridization; Neostriatum; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA, Messenger

1998
An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol.
    Brain research, 1999, Feb-06, Volume: 818, Issue:1

    Topics: Animals; Blood-Brain Barrier; Caffeine; Cells, Cultured; Colchicine; Culture Media, Serum-Free; Endothelium, Vascular; Haloperidol; Mannitol; Retinoids; Sucrose; Swine

1999
Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Neuroscience, 1999, Volume: 89, Issue:3

    Topics: Adenosine; Animals; Antipsychotic Agents; Behavior, Animal; Caffeine; Catalepsy; Clozapine; Corpus Striatum; Cyclic AMP; Dopamine D2 Receptor Antagonists; Gene Expression Regulation; Genes, fos; GTP-Binding Protein alpha Subunits, Gs; Haloperidol; Nerve Tissue Proteins; Neurons; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, Purinergic P1; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Second Messenger Systems; Serotonin; Serotonin Antagonists; Theophylline

1999
The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Feb-13, Volume: 98, Issue:4

    Topics: Adenosine; Amphetamines; Animals; Caffeine; Catalepsy; Corpus Striatum; Dopamine Antagonists; Enkephalins; Gene Expression; Haloperidol; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Purinergic P1; RNA, Messenger

2001
An animal model of nicotinic-acid-induced vasodilation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response.
    Schizophrenia research, 2001, Jul-01, Volume: 50, Issue:3

    Topics: Animals; Antipsychotic Agents; Brain; Caffeine; Cerebrovascular Circulation; Disease Models, Animal; Haloperidol; Male; Niacin; Nicotine; Rats; Rats, Sprague-Dawley; Schizophrenia; Vasodilation

2001
Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy.
    Neuropharmacology, 2003, Volume: 45, Issue:4

    Topics: Animals; Caffeine; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Male; Muscarinic Antagonists; Rats; Rats, Wistar

2003
Adenosine A2A receptors and depression.
    Neurology, 2003, Dec-09, Volume: 61, Issue:11 Suppl 6

    Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Caffeine; Depression; Disease Models, Animal; Dopamine Antagonists; Drug Interactions; Haloperidol; Mice; Mice, Knockout; Motor Activity; Neurotransmitter Agents; Parkinsonian Disorders; Purines; Pyrimidines; Receptor, Adenosine A2A; Triazines; Triazoles

2003
Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
    European journal of pharmacology, 2006, Dec-15, Volume: 552, Issue:1-3

    Topics: Adenosine; Akathisia, Drug-Induced; Animals; Antioxidants; Behavior, Animal; Brain; Caffeine; Catalase; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Haloperidol; Lipid Peroxidation; Male; Mastication; Maze Learning; Motor Activity; Neurotransmitter Agents; Rats; Rats, Wistar; Receptors, Purinergic P1; Stereotyped Behavior; Superoxide Dismutase; Vasodilator Agents

2006
Effects of N-n-butyl haloperidol iodide on L-type calcium channels and intracellular free calcium in rat ventricular myocytes.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 2007, Volume: 85, Issue:2

    Topics: Animals; Caffeine; Calcium; Calcium Channels, L-Type; Cells, Cultured; Central Nervous System Stimulants; Haloperidol; Heart Ventricles; Inositol 1,4,5-Trisphosphate; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Vasodilation

2007
The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
    Psychopharmacology, 2008, Volume: 200, Issue:3

    Topics: Adenosine A2 Receptor Antagonists; Animals; Antipsychotic Agents; Caffeine; Catalepsy; Cebus; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Globus Pallidus; Haloperidol; Neurologic Examination; Purines; Pyrimidines; Receptor, Adenosine A2A; Saimiri; Triazoles; Xanthines

2008
Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs.
    Nature neuroscience, 2008, Volume: 11, Issue:8

    Topics: Animals; Antipsychotic Agents; Caffeine; Central Nervous System Stimulants; Chromosomes, Artificial, Bacterial; Clozapine; Cocaine; Corpus Striatum; Dopamine and cAMP-Regulated Phosphoprotein 32; Globus Pallidus; Haloperidol; Mice; Mice, Transgenic; Neurons; Organ Culture Techniques; Phosphorylation; Substantia Nigra

2008
Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease.
    Journal of neuroscience methods, 2009, Apr-15, Volume: 178, Issue:2

    Topics: Analysis of Variance; Animals; Antiparkinson Agents; Caffeine; Catalepsy; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glutathione; Haloperidol; Levodopa; Male; Mice; Motor Activity; Parkinsonian Disorders; Posture; Superoxide Dismutase; Swimming

2009
Caffeine withdrawal retains anticataleptic activity but Withania somnifera withdrawal potentiates haloperidol-induced catalepsy in mice.
    Natural product research, 2009, Volume: 23, Issue:8

    Topics: Analysis of Variance; Animals; Caffeine; Catalepsy; Haloperidol; Mice; Nervous System; Plant Extracts; Withania

2009
Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.
    Behavioural brain research, 2009, Jul-19, Volume: 201, Issue:1

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Behavior, Animal; Caffeine; Central Nervous System Agents; Choice Behavior; Conditioning, Operant; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Feeding Behavior; Haloperidol; Male; Motivation; Purines; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Xanthines

2009
Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 92, Issue:3

    Topics: Animals; Caffeine; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Male; Parkinson Disease; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles

2009
Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice.
    Life sciences, 2009, Aug-12, Volume: 85, Issue:7-8

    Topics: Acetic Acid; Analgesia; Analgesics; Animals; Behavior, Animal; Benzene Derivatives; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Haloperidol; Male; Mice; Mice, Inbred ICR; Morphine; Motor Activity; Pain; Pain Measurement

2009
Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.
    Neuroscience letters, 2009, Oct-09, Volume: 463, Issue:3

    Topics: Animals; Caffeine; Catalepsy; Central Nervous System Stimulants; Disease Susceptibility; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Neuroprotective Agents; Rats; Rats, Wistar; Time Factors

2009
The stimulatory effects of caffeine with oseltamivir (Tamiflu) on light-dark behavior and open-field behavior in mice.
    Neuroscience letters, 2010, Jan-22, Volume: 469, Issue:2

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Antiviral Agents; Caffeine; Darkness; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Exploratory Behavior; Flumazenil; GABA Modulators; GABA-A Receptor Antagonists; Haloperidol; Male; Mice; Motor Activity; Neurotransmitter Agents; Oseltamivir; Pyrimidines; Random Allocation; Triazoles; Xanthines

2010
Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia.
    The American journal of psychiatry, 2010, Volume: 167, Issue:3

    Topics: Adult; Affect; Antipsychotic Agents; Arousal; Beverages; Caffeine; Central Nervous System Stimulants; Disease Progression; Dose-Response Relationship, Drug; Haloperidol; Humans; Injections, Intramuscular; Male; Psychoses, Substance-Induced; Schizophrenia, Paranoid

2010
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
    Anaesthesia, 2012, Volume: 67, Issue:9

    Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Creatine Kinase; Dantrolene; Disseminated Intravascular Coagulation; Female; Genetic Variation; Hallucinogens; Haloperidol; Halothane; Humans; Multiple Organ Failure; N-Methyl-3,4-methylenedioxyamphetamine; Neuroleptic Malignant Syndrome; Recurrence; Rhabdomyolysis; Ryanodine Receptor Calcium Release Channel; Spectrum Analysis; Young Adult

2012
Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats.
    Neuropharmacology, 2013, Volume: 70

    Topics: Animals; Caffeine; Catalepsy; Corpus Striatum; Dopaminergic Neurons; Dose-Response Relationship, Drug; Haloperidol; Male; Motor Skills; Oxidopamine; Parkinsonian Disorders; Rats; Theophylline

2013
Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice.
    Behavioural pharmacology, 2015, Volume: 26, Issue:1-2

    Topics: Animals; Antipsychotic Agents; Caffeine; Catalepsy; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Lipid Peroxidation; Male; Mice; Motor Activity; Parkinsonian Disorders; Tea

2015
Acute drug-induced spine changes in the nucleus accumbens are dependent on β-adducin.
    Neuropharmacology, 2016, Volume: 110, Issue:Pt A

    Topics: Animals; Caffeine; Cytoskeletal Proteins; Dendritic Spines; Dopamine and cAMP-Regulated Phosphoprotein 32; Female; Haloperidol; Male; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Nucleus Accumbens; Phosphorylation; Psychotropic Drugs; Quinpirole

2016
Sedative effect of Clozapine is a function of 5-HT
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2017, Volume: 27, Issue:1

    Topics: Animals; Antipsychotic Agents; Caffeine; Central Nervous System Stimulants; Clozapine; Dose-Response Relationship, Drug; Environment; Exploratory Behavior; Genotype; Haloperidol; Inhibition, Psychological; Mice; Mice, Knockout; Receptor, Serotonin, 5-HT2A; Risperidone; Serotonin Antagonists

2017
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2018, Volume: 28, Issue:4

    Topics: Animals; Brain; Caffeine; Central Nervous System Agents; Cytoskeletal Proteins; Drug Interactions; Drug Resistance; Gene Expression; Haloperidol; Homer Scaffolding Proteins; Male; Motor Activity; Nerve Tissue Proteins; Nicotine; Post-Synaptic Density; Psychotic Disorders; Random Allocation; Rats, Sprague-Dawley; RNA, Messenger; Schizophrenia

2018
Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice.
    Metabolic brain disease, 2018, Volume: 33, Issue:4

    Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Caffeine; Catalepsy; Cyclooxygenase Inhibitors; Haloperidol; Male; Mice; Motor Activity; Naproxen; Purinergic P1 Receptor Antagonists; Treatment Outcome

2018